These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 30130606)
1. Preclinical evaluation of thermosensitive poly(N-(2-hydroxypropyl) methacrylamide mono/dilactate)-grafted liposomes for cancer thermochemotherapy. van Elk M; van den Dikkenberg JB; Storm G; Hennink WE; Vermonden T; Heger M Int J Pharm; 2018 Oct; 550(1-2):190-199. PubMed ID: 30130606 [TBL] [Abstract][Full Text] [Related]
2. Triggered release of doxorubicin from temperature-sensitive poly(N-(2-hydroxypropyl)-methacrylamide mono/dilactate) grafted liposomes. van Elk M; Deckers R; Oerlemans C; Shi Y; Storm G; Vermonden T; Hennink WE Biomacromolecules; 2014 Mar; 15(3):1002-9. PubMed ID: 24476227 [TBL] [Abstract][Full Text] [Related]
4. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy. Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188 [TBL] [Abstract][Full Text] [Related]
5. Temperature-triggered tumor-specific delivery of anticancer agents by cRGD-conjugated thermosensitive liposomes. Kim MS; Lee DW; Park K; Park SJ; Choi EJ; Park ES; Kim HR Colloids Surf B Biointerfaces; 2014 Apr; 116():17-25. PubMed ID: 24441178 [TBL] [Abstract][Full Text] [Related]
6. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo. Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435 [TBL] [Abstract][Full Text] [Related]
7. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors. Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073 [TBL] [Abstract][Full Text] [Related]
8. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound. Kim HR; You DG; Park SJ; Choi KS; Um W; Kim JH; Park JH; Kim YS Mol Pharm; 2016 May; 13(5):1528-39. PubMed ID: 26998616 [TBL] [Abstract][Full Text] [Related]
9. Chitooligosaccharides Modified Reduction-Sensitive Liposomes: Enhanced Cytoplasmic Drug Delivery and Osteosarcomas-Tumor Inhibition in Animal Models. Yin X; Chi Y; Guo C; Feng S; Liu J; Sun K; Wu Z Pharm Res; 2017 Oct; 34(10):2172-2184. PubMed ID: 28726003 [TBL] [Abstract][Full Text] [Related]
10. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU). Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213 [TBL] [Abstract][Full Text] [Related]
11. Enhanced Specificity and Drug Delivery in Tumors by cRGD-Anchoring Thermosensitive Liposomes. Dicheva BM; ten Hagen TL; Seynhaeve AL; Amin M; Eggermont AM; Koning GA Pharm Res; 2015 Dec; 32(12):3862-76. PubMed ID: 26202516 [TBL] [Abstract][Full Text] [Related]
12. A novel two-step mild hyperthermia for advanced liposomal chemotherapy. Li L; ten Hagen TL; Haeri A; Soullié T; Scholten C; Seynhaeve AL; Eggermont AM; Koning GA J Control Release; 2014 Jan; 174():202-8. PubMed ID: 24269966 [TBL] [Abstract][Full Text] [Related]
13. NIR responsive liposomal system for rapid release of drugs in cancer therapy. Chen MM; Liu YY; Su GH; Song FF; Liu Y; Zhang QQ Int J Nanomedicine; 2017; 12():4225-4239. PubMed ID: 28652729 [TBL] [Abstract][Full Text] [Related]
14. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer. VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085 [TBL] [Abstract][Full Text] [Related]
15. Formulation and optimization of idarubicin thermosensitive liposomes provides ultrafast triggered release at mild hyperthermia and improves tumor response. Lu T; Lokerse WJM; Seynhaeve ALB; Koning GA; Ten Hagen TLM J Control Release; 2015 Dec; 220(Pt A):425-437. PubMed ID: 26541464 [TBL] [Abstract][Full Text] [Related]
16. Development of a bone targeted thermosensitive liposomal doxorubicin formulation based on a bisphosphonate modified non-ionic surfactant. Song H; Zhang J; Liu X; Deng T; Yao P; Zhou S; Yan W Pharm Dev Technol; 2016 Sep; 21(6):680-7. PubMed ID: 25975585 [TBL] [Abstract][Full Text] [Related]
17. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma. Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395 [TBL] [Abstract][Full Text] [Related]
19. Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Ning S; Macleod K; Abra RM; Huang AH; Hahn GM Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):827-34. PubMed ID: 8040030 [TBL] [Abstract][Full Text] [Related]
20. Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With Santos MA; Goertz DE; Hynynen K Theranostics; 2017; 7(10):2718-2731. PubMed ID: 28819458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]